Related Experiment Video
Updated: Jan 21, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Disease Recurrence-The Sword of Damocles in Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis
Katrin Kienzl-Wagner1, Siegfried Waldegger2, Stefan Schneeberger1
1Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Abstract:
A major obstacle in kidney transplantation for primary focal segmental glomerulosclerosis (FSGS) is the risk of disease recurrence. Recurrent FSGS affects up to 60% of first kidney grafts and exceeds 80% in patients who have lost their first graft due to recurrent FSGS. Clinical and experimental evidence support the hypothesis that a circulating permeability factor is the mediator in the pathogenesis of primary and recurrent disease. Despite all efforts, the causing agent has not yet been identified. Several treatment options for the management of recurrent FSGS have been proposed. In addition to plasma exchange, B-cell depleting antibodies are effective in recurrent FSGS. This indicates, that the secretion and/or activity of the postulated circulating permeability factor(s) may be B-cell related. This review summarizes the current knowledge on permeability factor(s) possibly related to the disease and discusses strategies for the management of recurrent FSGS. These include profound B-cell depletion prior to transplantation, as well as the salvage of an allograft affected by recurrent FSGS by transfer into a second recipient.
Insights
Recurrent focal segmental glomerulosclerosis (FSGS) after kidney transplant is common. B-cell therapies show promise for managing this condition, potentially by targeting a circulating permeability factor.
Area of Science:
- Nephrology
- Transplantation Immunology
Background:
- Primary focal segmental glomerulosclerosis (FSGS) poses a significant risk of recurrence in kidney transplant recipients.
- Recurrent FSGS affects a substantial proportion of kidney grafts, particularly in patients with prior graft loss due to the disease.
Purpose of the Study:
- To review current knowledge on permeability factors implicated in FSGS pathogenesis.
- To discuss management strategies for recurrent FSGS, focusing on B-cell related therapies and graft salvage.
Main Methods:
- Review of clinical and experimental evidence supporting the role of circulating permeability factors in FSGS.
- Analysis of treatment options for recurrent FSGS, including plasma exchange and B-cell depletion.
Main Results:
- Evidence suggests a circulating permeability factor mediates FSGS, though the agent remains unidentified.
- B-cell depleting antibodies demonstrate effectiveness in managing recurrent FSGS, indicating a potential B-cell link.
Conclusions:
- Profound B-cell depletion before transplantation may prevent recurrence.
- Salvaging a kidney allograft affected by recurrent FSGS via transfer to a second recipient is a potential strategy.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease I: Introduction
Kidney Transplant III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care

